Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Preferred Shares (2020 - 2022)

Spero Therapeutics' Preferred Shares history spans 3 years, with the latest figure at $2000.0 for Q2 2022.

  • For Q2 2022, Preferred Shares fell 33.33% year-over-year to $2000.0; the TTM value through Jun 2022 reached $2000.0, down 33.33%, while the annual FY2021 figure was $3000.0, 0.0% changed from the prior year.
  • Preferred Shares reached $2000.0 in Q2 2022 per SPRO's latest filing, down from $3000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $3000.0 in Q3 2020 to a low of $2000.0 in Q2 2022.
  • Average Preferred Shares over 3 years is $2875.0, with a median of $3000.0 recorded in 2020.
  • Peak YoY movement for Preferred Shares: changed 0.0% in 2021, then tumbled 33.33% in 2022.
  • A 3-year view of Preferred Shares shows it stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then tumbled by 33.33% to $2000.0 in 2022.
  • Per Business Quant, the three most recent readings for SPRO's Preferred Shares are $2000.0 (Q2 2022), $3000.0 (Q1 2022), and $3000.0 (Q4 2021).